Tscan Therapeutics, Inc. (TCRX) — SC 13D/A Filings
All SC 13D/A filings from Tscan Therapeutics, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Baker Bros. Advisors Amends TScan Therapeutics Stake
— Apr 23, 2024 Risk: medium
Baker Bros. Advisors LP, through its general partner Baker Bros. Advisors (GP) LLC and principals Felix J. Baker and Julian C. Baker, has amended its Schedule 1
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX